NCT00039676

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

RecruitingOBSERVATIONAL

Trial Details

Start: 2002-07-08

Enrollment target: 1,836 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
NIH National Cancer Institute - Shady Grove, Rockville, Maryland, United States

Other microbiome trials you might be interested in

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesPhase 1Recruiting

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Diffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)Waldenstrom Macroglobulinemia (WM)Primary Central Nervous System Lymphoma (PCNSL)Secondary Central Nervous System Lymphoma (SCNSL)

This is a first-in-human Phase 1a/1b multicenter, open-label study designed to evaluate the safety and anti-cancer activ…

Duarte, United StatesEst. completion Jan 2027

View Trial →

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.